BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1324 related articles for article (PubMed ID: 23348506)

  • 1. Highly recurrent TERT promoter mutations in human melanoma.
    Huang FW; Hodis E; Xu MJ; Kryukov GV; Chin L; Garraway LA
    Science; 2013 Feb; 339(6122):957-9. PubMed ID: 23348506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERT promoter mutations in familial and sporadic melanoma.
    Horn S; Figl A; Rachakonda PS; Fischer C; Sucker A; Gast A; Kadel S; Moll I; Nagore E; Hemminki K; Schadendorf D; Kumar R
    Science; 2013 Feb; 339(6122):959-61. PubMed ID: 23348503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.
    Makowski MM; Willems E; Fang J; Choi J; Zhang T; Jansen PW; Brown KM; Vermeulen M
    Proteomics; 2016 Feb; 16(3):417-26. PubMed ID: 26553150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.
    Vallarelli AF; Rachakonda PS; André J; Heidenreich B; Riffaud L; Bensussan A; Kumar R; Dumaz N
    Oncotarget; 2016 Aug; 7(33):53127-53136. PubMed ID: 27449293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tert promoter mutations in melanoma: not only the MAP-kinase pathway].
    Dereure O
    Ann Dermatol Venereol; 2013; 140(6-7):487-8. PubMed ID: 23773757
    [No Abstract]   [Full Text] [Related]  

  • 6. TERT promoter mutations in cancer development.
    Heidenreich B; Rachakonda PS; Hemminki K; Kumar R
    Curr Opin Genet Dev; 2014 Feb; 24():30-7. PubMed ID: 24657534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of TERT promoter mutations in primary tumors of the liver.
    Quaas A; Oldopp T; Tharun L; Klingenfeld C; Krech T; Sauter G; Grob TJ
    Virchows Arch; 2014 Dec; 465(6):673-7. PubMed ID: 25267585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
    Cevik D; Yildiz G; Ozturk M
    World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
    Avin BA; Wang Y; Gilpatrick T; Workman RE; Lee I; Timp W; Umbricht CB; Zeiger MA
    Genes Chromosomes Cancer; 2019 Aug; 58(8):530-540. PubMed ID: 30664813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
    Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
    Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma.
    Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO
    Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.
    Huang DS; Wang Z; He XJ; Diplas BH; Yang R; Killela PJ; Meng Q; Ye ZY; Wang W; Jiang XT; Xu L; He XL; Zhao ZS; Xu WJ; Wang HJ; Ma YY; Xia YJ; Li L; Zhang RX; Jin T; Zhao ZK; Xu J; Yu S; Wu F; Liang J; Wang S; Jiao Y; Yan H; Tao HQ
    Eur J Cancer; 2015 May; 51(8):969-76. PubMed ID: 25843513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
    Rachakonda PS; Hosen I; de Verdier PJ; Fallah M; Heidenreich B; Ryk C; Wiklund NP; Steineck G; Schadendorf D; Hemminki K; Kumar R
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17426-31. PubMed ID: 24101484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma.
    Chun-On P; Hinchie AM; Beale HC; Gil Silva AA; Rush E; Sander C; Connelly CJ; Seynnaeve BKN; Kirkwood JM; Vaske OM; Greider CW; Alder JK
    Science; 2022 Nov; 378(6620):664-668. PubMed ID: 36356143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.
    Li CL; Li CY; Lin YY; Ho MC; Chen DS; Chen PJ; Yeh SH
    Hepatology; 2019 Feb; 69(2):498-512. PubMed ID: 30070724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.
    Yuan X; Dai M; Xu D
    Cancer Lett; 2020 Nov; 493():1-9. PubMed ID: 32768523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TERT promoter mutations in telomere biology.
    Heidenreich B; Kumar R
    Mutat Res Rev Mutat Res; 2017; 771():15-31. PubMed ID: 28342451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
    Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
    Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
    Yang X; Guo X; Chen Y; Chen G; Ma Y; Huang K; Zhang Y; Zhao Q; Winkler CA; An P; Lyu J
    Oncotarget; 2016 May; 7(19):27838-47. PubMed ID: 27056898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase Reverse Transcriptase Promoter Mutations in Human Hepatobiliary, Pancreatic and Gastrointestinal Cancer Cell Lines.
    Hirata M; Fujita K; Fujihara S; Mizuo T; Nakabayashi R; Kono T; Namima D; Fujita N; Yamana H; Kamada H; Tani J; Kobara H; Tsutsui K; Matsuda Y; Ono M; Masaki T
    In Vivo; 2022; 36(1):94-102. PubMed ID: 34972704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.